2014
DOI: 10.4172/1747-0862.s1-009
|View full text |Cite
|
Sign up to set email alerts
|

Prevention and Treatment of Obesity and Diabetes and their Related Complications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2017
2017

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 97 publications
(116 reference statements)
0
2
0
Order By: Relevance
“…In addition, the amylase inhibitors have also been reported for the treatment of rumen acidosis (Banks et al 2001). Microbial α-amylase inhibitors are paim from Streptomyces corchorushii and TAI-A and TAI-B from Streptomyces calvus TM-521 (Song et al 2014). The clavulanic acid is derived from Streptomyces clavuligerus .…”
Section: Other Therapeutic Agentsmentioning
confidence: 99%
“…In addition, the amylase inhibitors have also been reported for the treatment of rumen acidosis (Banks et al 2001). Microbial α-amylase inhibitors are paim from Streptomyces corchorushii and TAI-A and TAI-B from Streptomyces calvus TM-521 (Song et al 2014). The clavulanic acid is derived from Streptomyces clavuligerus .…”
Section: Other Therapeutic Agentsmentioning
confidence: 99%
“…The use of amylase inhibitors for the treatment of rumen acidosis has also been reported [17]. Examples of microbial α-amylase inhibitors are paim, obtained from culture filtrates of Streptomyces corchorushii, and TAI-A, TAI-B, oligosaccharide compounds from Streptomyces calvus TM-521 [18]. Lipstatin is a pancreatic lipase inhibitor produced by Streptomyces toxytricini that is used to combat obesity and diabetes.…”
Section: Microbes As Enzyme Inhibitorsmentioning
confidence: 99%